Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol

INTRODUCTION: Decision models can be used to conduct economic evaluations of new pharmacogenetic and pharmacogenomic tests to ensure they offer value for money to healthcare systems. These models require a great deal of evidence, yet research suggests the evidence used is diverse and of uncertain qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Jaime L, Cooper, Chris, Buchanan, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654339/
https://www.ncbi.nlm.nih.gov/pubmed/26560056
http://dx.doi.org/10.1136/bmjopen-2015-008465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654339/
https://www.ncbi.nlm.nih.gov/pubmed/26560056
http://dx.doi.org/10.1136/bmjopen-2015-008465

Ejemplares similares